Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Construction in Progress (2024 - 2026)

Neuroone Medical Technologies filings provide 3 years of Construction in Progress readings, the most recent being $292314.0 for Q1 2026.

  • On a quarterly basis, Construction in Progress changed N/A to $292314.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $292314.0, a N/A change, with the full-year FY2025 number at $130100.0, down 32.37% from a year prior.
  • Construction in Progress hit $292314.0 in Q1 2026 for Neuroone Medical Technologies, up from $135244.0 in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $292314.0 in Q1 2026 to a low of $130100.0 in Q3 2025.
  • Median Construction in Progress over the past 3 years was $163802.0 (2024), compared with a mean of $187504.5.
  • The widest YoY moves for Construction in Progress: up 32.37% in 2025, down 32.37% in 2025.
  • Neuroone Medical Technologies' Construction in Progress stood at $192360.0 in 2024, then decreased by 29.69% to $135244.0 in 2025, then skyrocketed by 116.14% to $292314.0 in 2026.
  • The last three reported values for Construction in Progress were $292314.0 (Q1 2026), $135244.0 (Q4 2025), and $130100.0 (Q3 2025) per Business Quant data.